Winton Group LTD Care Dx, Inc. Transaction History

Winton Group LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$7.0 - $11.26 $72,009 - $115,831	10,287 New	10,287 $72,000
Q2 2022 Aug 10, 2022	BUY	$20.49 - $39.72 $210,493 - $408,043	10,273 New	10,273 $221,000
Q1 2022 May 11, 2022	SELL	$28.19 - $46.6 $238,882 - $394,888	-8,474 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$41.2 - $73.6 $349,128 - $623,686	8,474 New	8,474 $385,000
Q1 2020 May 11, 2020	SELL	$13.94 - $28.25 $304,310 - $616,697	-21,830 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$19.24 - $28.41 $420,009 - $620,190	21,830 New	21,830 $471,000
Q2 2019 Jul 08, 2019	SELL	$25.78 - $39.77 $237,201 - $365,923	-9,201 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$22.09 - $39.21 $203,250 - $360,771	9,201 New	9,201 $290,000

218

51.1M

97.3K

43.3K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.15B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.